These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 25098287)

  • 1. Biochemical signaling of PD-1 on T cells and its functional implications.
    Boussiotis VA; Chatterjee P; Li L
    Cancer J; 2014; 20(4):265-71. PubMed ID: 25098287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PD-1/PD-Ls pathway and autoimmune diseases.
    Dai S; Jia R; Zhang X; Fang Q; Huang L
    Cell Immunol; 2014 Jul; 290(1):72-9. PubMed ID: 24908630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation.
    Bardhan K; Anagnostou T; Boussiotis VA
    Front Immunol; 2016; 7():550. PubMed ID: 28018338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PD-1 pathway in tolerance and autoimmunity.
    Francisco LM; Sage PT; Sharpe AH
    Immunol Rev; 2010 Jul; 236():219-42. PubMed ID: 20636820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1, gender, and autoimmunity.
    Dinesh RK; Hahn BH; Singh RP
    Autoimmun Rev; 2010 Jun; 9(8):583-7. PubMed ID: 20433954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-1 as an immune modulatory receptor.
    Yao S; Chen L
    Cancer J; 2014; 20(4):262-4. PubMed ID: 25098286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered Dendritic Cell-Directed Concurrent Activation of Multiple T cell Inhibitory Pathways Induces Robust Immune Tolerance.
    Gudi RR; Karumuthil-Melethil S; Perez N; Li G; Vasu C
    Sci Rep; 2019 Aug; 9(1):12065. PubMed ID: 31427630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.
    Fife BT; Bluestone JA
    Immunol Rev; 2008 Aug; 224():166-82. PubMed ID: 18759926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An optimized protocol for the in vitro generation and functional analysis of human PD1/PD-L1 signal.
    Khedri M; Abnous K; Rafatpanah H; Ramezani M
    J Recept Signal Transduct Res; 2018 Feb; 38(1):31-36. PubMed ID: 29252078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The programmed death-1 immune-suppressive pathway: barrier to antitumor immunity.
    Ostrand-Rosenberg S; Horn LA; Haile ST
    J Immunol; 2014 Oct; 193(8):3835-41. PubMed ID: 25281753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-1 signaling pathway in sepsis: Does it have a future?
    Chen R; Zhou L
    Clin Immunol; 2021 Aug; 229():108742. PubMed ID: 33905818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis].
    Wen SL; Li F; Zhao F; Zuo JJ; Deng YQ; Zhang W; Tao ZZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):384-390. PubMed ID: 32306637
    [No Abstract]   [Full Text] [Related]  

  • 13. Tissue expression of PD-L1 mediates peripheral T cell tolerance.
    Keir ME; Liang SC; Guleria I; Latchman YE; Qipo A; Albacker LA; Koulmanda M; Freeman GJ; Sayegh MH; Sharpe AH
    J Exp Med; 2006 Apr; 203(4):883-95. PubMed ID: 16606670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance.
    Park JJ; Omiya R; Matsumura Y; Sakoda Y; Kuramasu A; Augustine MM; Yao S; Tsushima F; Narazaki H; Anand S; Liu Y; Strome SE; Chen L; Tamada K
    Blood; 2010 Aug; 116(8):1291-8. PubMed ID: 20472828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer.
    Diskin B; Adam S; Cassini MF; Sanchez G; Liria M; Aykut B; Buttar C; Li E; Sundberg B; Salas RD; Chen R; Wang J; Kim M; Farooq MS; Nguy S; Fedele C; Tang KH; Chen T; Wang W; Hundeyin M; Rossi JAK; Kurz E; Haq MIU; Karlen J; Kruger E; Sekendiz Z; Wu D; Shadaloey SAA; Baptiste G; Werba G; Selvaraj S; Loomis C; Wong KK; Leinwand J; Miller G
    Nat Immunol; 2020 Apr; 21(4):442-454. PubMed ID: 32152508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies.
    Shi L; Chen S; Yang L; Li Y
    J Hematol Oncol; 2013 Sep; 6(1):74. PubMed ID: 24283718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD279 mediates the homeostasis and survival of regulatory T cells by enhancing T cell and macrophage interactions.
    Liu Y; Gao Y; Hao H; Hou T
    FEBS Open Bio; 2020 Jun; 10(6):1162-1170. PubMed ID: 32324337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape.
    Jiang X; Wang J; Deng X; Xiong F; Ge J; Xiang B; Wu X; Ma J; Zhou M; Li X; Li Y; Li G; Xiong W; Guo C; Zeng Z
    Mol Cancer; 2019 Jan; 18(1):10. PubMed ID: 30646912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the PD-1 pathway in autoimmunity and peripheral tolerance.
    Fife BT; Pauken KE
    Ann N Y Acad Sci; 2011 Jan; 1217():45-59. PubMed ID: 21276005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of T-cell function by PD-1.
    Zha Yy; Blank C; Gajewski TF
    Crit Rev Immunol; 2004; 24(4):229-37. PubMed ID: 15588223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.